GLP
Scope
Date
~
-
Bio & PharmaKobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Jan 17, 2024 (Gmt+09:00)
-
Bio & PharmaHanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Real estateIGIS beats Blackstone, Brookfield in Asian real estate AUM
IGIS Asset Management Co., South Korea’s largest real estate asset manager, was ranked as the world’s second-largest asset management ...
Nov 24, 2021 (Gmt+09:00)
-
Artificial intelligenceNPS, KIC commit $600 mn to N.America logistics fund
The National Pension Service (NPS) and the Korea Investment Corporation (KIC) have committed $600 million in aggregate to GLP Capital Partners' Nort...
May 28, 2021 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand
